{
    "id": "0297",
    "question": "Two days after being admitted to the hospital following a fall, a 77-year-old woman complains of fatigue and headaches. During the fall she sustained a right-sided subdural hematoma. She has hypertension and hyperlipidemia. Her medications prior to admission were hydrochlorothiazide and atorvastatin. Vital signs are within normal limits. Physical and neurologic examinations show no abnormalities. Laboratory studies show:\nSerum\nNa+ 130 mEq/L\nK+ 4.0 mEq/L\nCl- 103 mEq/L\nHCO3- 24 mEq/L\nUrea nitrogen 14 mg/dL\nCreatinine 1.1 mg/dL\nOsmolality 270 mOsmol/kg H2O\nUrine\nSodium 45 mEq/L\nOsmolality 326 mOsmol/kg H2O\nA CT scan of the head shows an unchanged right-sided subdural hematoma. Which of the following is the most appropriate next step in management?\"",
    "options": {
        "A": "Head elevation",
        "B": "Tolvaptan",
        "C": "Desmopressin",
        "D": "Fluid restriction"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To approach this question, we need to analyze the patient's laboratory results and clinical presentation. The patient has a right-sided subdural hematoma, which is a serious condition that requires close monitoring. The patient's serum sodium level is 130 mEq/L, which is slightly low, but not severely hyponatremic. The urine sodium level is 45 mEq/L, which is low, indicating that the kidneys are trying to conserve sodium. The urine osmolality is 326 mOsmol/kg H2O, which is high, indicating that the kidneys are trying to concentrate urine. The patient's serum osmolality is 270 mOsmol/kg H2O, which is low, indicating hyponatremia. However, the patient is not showing any symptoms of severe hyponatremia, such as seizures, confusion, or coma. Given the patient's clinical presentation and laboratory results, the most appropriate next step in management is to monitor the patient closely for any signs of worsening hyponatremia or cerebral edema. Since the patient is not showing any symptoms of severe hyponatremia, fluid restriction is not necessary at this time. The other options are not appropriate: * Head elevation (A) may be beneficial for patients with cerebral edema, but there is no evidence of edema in this patient. * Tolvaptan (B) is a vasopressin receptor antagonist that is used to treat euvolemic hyponatremia, but this patient has a high urine sodium level, which suggests that the patient is euvolemic and does not need vasopressin antagonism. * Desmopressin (C) is a vasopressin analog that is used to treat central diabetes insipidus and euvolemic hyponatremia, but this patient has a high urine sodium level and is not showing any symptoms of central diabetes insipidus. Therefore, the most appropriate next step in management is to monitor the patient closely for any signs of worsening hyponatremia or cerebral edema, and to re-evaluate the patient's fluid status and electrolyte levels regularly.\", \"answer_choice\": \"D\"}}",
    "snippets": [
        {
            "id": "Neurology_Adams_7147",
            "title": "Neurology_Adams",
            "content": "The effects of mannitol have been of great interest to those who treat head trauma, but the ideal plan for its use has never been established. If ICP exceeds a predetermined level, for example, 20 mm Hg as recommended by aforementioned guidelines for the treatment of traumatic brain injury, mannitol 20 percent, 0.25 to 1.0 g/kg is given every 3 to 6 h to maintain serum sodium above approximately 142 mEq/L and osmolarity of 290 to 315 mOsm/L. Even if ICP monitoring is not used, an attempt may be made to maintain this level of serum osmolality for the first days after injury if contusion and brain swelling are detected on the CT scan. Mannitol in large amounts may cause renal failure, almost always reversible, though an uncertain mechanism perhaps having to do with renal blood flow. Limited evidence suggests that this complication occurs only with the use of more than 200 g of mannitol daily."
        },
        {
            "id": "InternalMed_Harrison_3630",
            "title": "InternalMed_Harrison",
            "content": "A 78-year-old man was admitted with pneumonia and hyponatremia. Plasma Na+ concentration was initially 129 meq/L, decreasing within 3 days to 118\u2013120 meq/L despite fluid restriction to 1 L/d. A chest computed tomography (CT) revealed a right 2.8 \u00d7 1.6 cm infrahilar mass and postobstructive pneumonia. The patient was an active smoker. Past medical history was notable for laryngeal carcinoma treated 15 years prior with radiation therapy, renal cell carcinoma, peripheral vascular disease, and hypothyroidism. On review of systems, he denied headache, nausea, and vomiting. He had chronic hip pain, managed with acetaminophen with codeine. Other medications included cilostazol, amoxicillin/clavulanate, digoxin, diltiazem, and thyroxine. He was euvolemic on examination, with no lymphadenopathy and a normal chest examination. Na+ 120 K+ 4.3 Cl\u2212 89 HCO3\u2212 23 BUN 8 Creat 1.0 Glu 93 Alb 3.1 Ca 8.9 Phos 2.8 Mg 2.0 Plasma osm 248 mOsm/kg Cortisol 25 \u03bcg/dL TSH 2.6 Uric acid 2.7 mg/dL"
        },
        {
            "id": "InternalMed_Harrison_3631",
            "title": "InternalMed_Harrison",
            "content": "Na+ 120 K+ 4.3 Cl\u2212 89 HCO3\u2212 23 BUN 8 Creat 1.0 Glu 93 Alb 3.1 Ca 8.9 Phos 2.8 Mg 2.0 Plasma osm 248 mOsm/kg Cortisol 25 \u03bcg/dL TSH 2.6 Uric acid 2.7 mg/dL Urine: Na+ 97 K+ 22 Cl\u2212 86 Osm 597 The patient was treated with furosemide, 20 mg PO bid, and salt tablets. The plasma Na+ concentration increased to 129 meq/L with this therapy; however, the patient developed orthostatic hypotension and dizziness. He was started on demeclocycline, 600 mg PO in the morning and 300 mg in the evening, just before discharge from hospital. Plasma Na+ concentration increased to 140 meq/L with a BUN of 23 and creatinine of 1.4, at which point demeclocycline was reduced to 300 mg PO bid. Bronchoscopic biopsy eventually showed small-cell lung cancer; the patient declined chemotherapy and was admitted to hospice. What factors contributed to this patient\u2019s hyponatremia? What are the therapeutic options?"
        },
        {
            "id": "InternalMed_Harrison_3617",
            "title": "InternalMed_Harrison",
            "content": "A 63-year-old man was admitted to the intensive care unit (ICU) with a severe aspiration pneumonia. Past medical history included schizophrenia, for which he required institutional care; treatment had included neuroleptics and intermittent lithium, the latter restarted 6 months before admission. The patient was treated with antibiotics and intubated for several days, with the development of polyuria (3\u20135 L/d), hypernatremia, and acute renal insufficiency; the peak plasma Na+ concentration was 156 meq/L, and peak creatinine was 2.6 mg/dL. Urine osmolality was measured once and reported as 157 mOsm/kg, with a coincident plasma osmolality of 318 mOsm/kg. Lithium was stopped on admission to the ICU. On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W."
        },
        {
            "id": "InternalMed_Harrison_3642",
            "title": "InternalMed_Harrison",
            "content": "The plasma Na+ concentration on admission was 113 meq/L, with a creatinine of 2.35 (Table 64e-1). At hospital hour 7, the plasma Na+ concentration was 120 meq/L, potassium 5.4 meq/L, chloride 90 64e-5 meq/L, bicarbonate 22 meq/L, BUN 32 mg/dL, creatinine 2.02 mg/dL, glucose 89 mg/dL, total protein 5.0, and albumin 1.9. The hematocrit was 33.9, white count 7.6, and platelets 405. A morning cortisol was 19.5, with thyroid-stimulating hormone (TSH) of 1.7. The patient was treated with 1 \u03bcg of intravenous DDAVP, along with 75 mL/h of intravenous half-normal saline. After the plasma Na+ concentration dropped to 116 meq/L, intravenous fluid was switched to normal saline at the same infusion rate. The subsequent results are shown in Table 64e-1."
        },
        {
            "id": "InternalMed_Harrison_3685",
            "title": "InternalMed_Harrison",
            "content": "A stuporous 22-year-old man was admitted with a history of behaving strangely. His friends indicated he experienced recent emotional problems stemming from a failed relationship and had threatened suicide. There was a history of alcohol abuse, but his friends were unaware of recent alcohol consumption. The patient was obtunded on admission, with no evident focal neurologic deficits. The remainder of the physical examination was unremarkable. Na+ 140 meq/L K+ 5 meq/L Cl\u2212 95 meq/L HCO3\u2212 10 meq/L Glucose 125 mg/dL BUN 15 mg/dL Creatinine 0.9 mg/dL Ionized calcium 4.0 mg/dL Plasma osmolality 325 mOsm kg/H2O Urinalysis revealed crystalluria, with a mixture of envelope-shaped and needle-shaped crystals."
        },
        {
            "id": "Neurology_Adams_4475",
            "title": "Neurology_Adams",
            "content": "A fall in serum sodium to 125 mEq/L usually has few clinical effects, although signs of an associated neurologic disease, such as a previous stroke or a subdural hematoma, may worsen. Sodium levels of less than 120 mEq/L are attended by nausea and vomiting, inattentiveness, drowsiness, stupor, and generalized seizures. There may be asterixis. As is characteristic of most metabolic encephalopathies, the more rapid the decline of the serum sodium, the more likely there will be accompanying neurologic symptoms."
        },
        {
            "id": "First_Aid_Step2_1102",
            "title": "First_Aid_Step2",
            "content": "Treat the underlying causes and replace free-water deficit with hypotonic saline, D5W, or oral water, depending on volume status. Correction of chronic hypernatremia (> 36\u201348 hours) should be accomplished gradually over 48\u201372 hours (\u2264 0.5 mEq/L/hr) to prevent neurologic damage 2\u00b0 to cerebral edema. Serum sodium < 135 mEq/L. Almost always due to \u2191 ADH. May be asymptomatic or may present with confusion, lethargy, muscle cramps, hypore\ufb02exia, and nausea. Can progress to seizures, coma, or brain stem herniation. Hyponatremia can be categorized according to serum and urine osmolality as well as by volume status (i.e., by clinical exam). Osmolality is classified as follows: High (> 295 mEq/L): Hyperglycemia, hypertonic infusion (e.g., mannitol). Normal (280\u2013295 mEq/L): Hypertriglyceridemia, paraproteinemia (pseudohyponatremia)."
        },
        {
            "id": "InternalMed_Harrison_3649",
            "title": "InternalMed_Harrison",
            "content": "Creatinine (mg/dL) 1.2 2.35 2.10 2.02 1.97 1.79 1.53 1.20 1.13 days after DDAVP administration. It is 64e-6 conceivable that residual hypovolemic hyponatremia attenuated the recovery of the plasma Na+ concentration. Alternatively, attenuated recovery was due to persistent effects of the single dose of DDAVP. Of note, although the plasma half-life of DDAVP is only 1\u20132 h, pharmacodynamic studies indicate a much more prolonged effect on urine output and/or urine osmolality. One final consideration is the effect of the patient\u2019s initial renal dysfunction on the pharmacokinetics and pharmacodynamics of the administered DDAVP, which is renally excreted; DDAVP should be administered with caution for the reinduction of hyponatremia in patients with chronic kidney disease or acute renal dysfunction. A 44-year-old woman was referred from a local hospital after presenting with flaccid paralysis. Severe hypokalemia was documented (2.0 meq/L), and an infusion containing KCl was initiated."
        },
        {
            "id": "InternalMed_Harrison_3656",
            "title": "InternalMed_Harrison",
            "content": "A 32-year-old man was admitted to the hospital with weakness and hypokalemia. The patient had been very healthy until 2 months previously when he developed intermittent leg weakness. His review of systems was otherwise negative. He denied drug or laxative abuse and was on no medications. Past medical history was unremarkable, with no history of neuromuscular disease. Family history was notable for a sister with thyroid disease. Physical examination was notable only for reduced deep tendon reflexes. Sodium 139 143 meq/L Potassium 2.0 3.8 meq/L Chloride 105 107 meq/L Bicarbonate 26 29 meq/L BUN 11 16 mg/dL Creatinine 0.6 1.0 mg/dL Calcium 8.8 8.8 mg/dL Phosphate 1.2 mg/dL Albumin 3.8 meq/L TSH 0.08 \u03bcIU/L (normal 0.2\u20135.39) Free T4 41 pmol/L (normal 10\u201327)"
        },
        {
            "id": "InternalMed_Harrison_3664",
            "title": "InternalMed_Harrison",
            "content": "A 66-year-old man was admitted to hospital with a plasma K+ concentration of 1.7 meq/L and profound weakness. The patient had noted progressive weakness over several days, to the point that he was unable to rise from bed. Past medical history was notable for small-cell lung cancer with metastases to brain, liver, and adrenals. The patient had been treated with one cycle of cisplatin/etoposide 1 year before this admission, which was complicated by acute kidney injury (peak creatinine of 5, with residual chronic kidney disease), and three subsequent cycles of cyclophosphamide/doxorubicin/vincristine, in addition to 15 treatments with whole-brain radiation. On physical examination, the patient was jaundiced. Blood pressure was 130/70 mmHg, increasing to 160/98 mmHg after 1 L of saline, with a JVP at 8 cm. There was generalized muscle weakness. Potassium 3.7 1.7 3.5 meq/L 7.47 Creatinine 2.8 2.9 2.3 mg/dL Magnesium 1.3 1.6 2.4 mg/dL Albumin 3.4 2.8 2.3 Total bilirubin 0.65 5.19 5.5"
        },
        {
            "id": "InternalMed_Harrison_3645",
            "title": "InternalMed_Harrison",
            "content": "The key concern in this case was the evident chronicity of the patient\u2019s hyponatremia, with several weeks of diarrhea followed by 2\u20133 days of acute exacerbation. This patient was judged to have chronic hyponatremia, i.e., with a suspected duration of >48 h; as such, she would be predisposed to osmotic demyelination were she to undergo too rapid a correction in her plasma Na+ concentration, i.e., by >8\u201310 meq/L in 24 h or 18 meq/L in 48 h. At presentation, she had no symptoms that one would typically attribute to acute hyponatremia, and the plasma Na+ concentration had already increased by a sufficient amount to protect from cerebral edema; however, she had corrected by 1 meq/L per hour within the first 7 h of admission, consistent with impending overcorrection. To reduce or halt the increase in plasma Na+ concentration, the patient received 1 \u03bcg of intravenous DDAVP along with intravenous free water. Given the hypovolemia and resolving acute renal insufficiency, a decision was made to"
        },
        {
            "id": "Neurology_Adams_4476",
            "title": "Neurology_Adams",
            "content": "Treatment of SIADH If hyponatremia has been of several days or more duration, the rapid restitution of serum sodium to normal or above-normal levels carries a risk of producing osmotic demyelination (also called central pontine myelinolysis; see Chap. 40). Our usual procedure in patients with serum sodium concentrations of 117 to 125 mEq/L is to slowly correct the sodium concentration by restricting water to 400 to 800 mL/d and to verify the desired urinary loss of water by checking the patient\u2019s weight and serum sodium until it reaches approximately 130 mEq/L. If there is drowsiness, confusion, or seizures that cannot be confidently attributed to the underlying neurologic illness, or if the serum sodium is in the range of 100 to 115 mEq/L, isotonic or 3 percent NaCl should be infused over 3 to 4 h and furosemide 20 to 40 mg administered to prevent fluid overload. In order to avoid osmotic demyelination, a safe clinical rule is to raise the serum sodium by no more than 12 mEq/L in the"
        },
        {
            "id": "Gynecology_Novak_3530",
            "title": "Gynecology_Novak",
            "content": "Normal serum osmolarity is typically 290 to 300 mOsm. Blood hematocrit will rise or fall inversely at a rate of 1% per 500-mL alteration of extracellular \ufb02uid volume. The BUN:creatinine ratio is typically 10:1 but will rise to a ratio of greater than 20:1 under conditions of extracellular \ufb02uid contraction. Under conditions of extracellular \ufb02uid deficit, urine osmolarity will typically be high (>400 mOsm), whereas urine sodium concentration is low (<15 mEq/L), indicative of an attempt by the kidney to conserve sodium. Under conditions of extracellular \ufb02uid excess or in cases of renal disease in which the kidney has impaired ability to retain sodium and water, urine osmolarity will be low and urine sodium will be high (>30 mEq/L). Changes in sodium can give insight into the degree of extracellular \ufb02uid excess or deficit. In the average person, the serum sodium rises by 3 mmol/L for every liter of water deficit and falls by 3 mmol/L for each liter of water excess. One must be careful in"
        },
        {
            "id": "InternalMed_Harrison_3643",
            "title": "InternalMed_Harrison",
            "content": "This patient presented with hypovolemic hyponatremia and a \u201cprerenal\u201d reduction in GFR, with an increase in serum creatinine. She had experienced diarrhea for some time and manifested an orthostatic tachycardia after a liter of normal saline. As expected for hypovolemic hyponatremia, the urine Na+ concentration was <20 meq/L in the absence of congestive heart failure or other causes of hypervolemic hyponatremia, and she responded to saline hydration with an increase in plasma Na+ concentration and a decrease in creatinine."
        },
        {
            "id": "InternalMed_Harrison_3752",
            "title": "InternalMed_Harrison",
            "content": "ALCOHOLS Under most physiologic conditions, sodium, urea, and glucose generate the osmotic pressure of blood. Plasma osmolality is calculated according to the following expression: Posm = 2Na+ + Glu + BUN (all in mmol/L), or, using conventional laboratory values in which glucose and BUN are expressed in milligrams per deciliter: Posm = 2Na+ + Glu/18 + BUN/2.8. The calculated and determined osmolality should agree within 10\u201315 mmol/kg H2O. When the measured osmolality exceeds the calculated osmolality by >10\u201315 mmol/kg H2O, one of two circumstances prevails. Either the serum sodium is spuriously low, as with hyperlipidemia or hyperproteinemia (pseudohyponatremia), or osmolytes other than sodium salts, glucose, or urea have accumulated in plasma. Examples of such osmolytes include mannitol, radiocontrast media, ethanol, isopropyl alcohol, ethylene glycol, propylene glycol, methanol, and acetone. In this situation, the difference between the calculated osmolality and the measured"
        },
        {
            "id": "InternalMed_Harrison_3628",
            "title": "InternalMed_Harrison",
            "content": "For this patient, the CeH2O was 2.5 L/d when initially evaluated, i.e., with urine Na+ and K+ concentrations of 34 and 5.2 meq/L, plasma Na+ concentration of 150 meq/L, and a urinary volume of 3.4 L. Therefore, the patient was given 2.5 L of D5W over the first 24 h to replace ongoing free water losses, along with 2.1 L of D5W to replace half his free water deficit. Daily random urine electrolytes and urinary volume measurement can be used to monitor CeH2O and adjust daily fluid administration in this manner, while following plasma Na+ concentration. Physicians often calculate the free water deficit to guide therapy of hypernatremia, providing half the deficit in the first 24 h. This approach can be adequate in patients who do not have significant ongoing losses of free water, e.g., with hypernatremia due to decreased free water intake. This case illustrates how free water requirements can be grossly underestimated in hypernatremic patients if ongoing, daily free water losses are not"
        },
        {
            "id": "InternalMed_Harrison_3597",
            "title": "InternalMed_Harrison",
            "content": "Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples David B. Mount, Thomas D. DuBose, Jr. CASE 1 64e A 23-year-old woman was admitted with a 3-day history of fever, cough productive of blood-tinged sputum, confusion, and orthostasis. Past medical history included type 1 diabetes mellitus. A physical examination in the emergency department indicated postural hypo-tension, tachycardia, and Kussmaul respiration. The breath was noted to smell of \u201cacetone.\u201d Examination of the thorax suggested consolidation in the right lower lobe. Sodium 130 meq/L Potassium 5.0 meq/L Chloride 96 meq/L CO2 14 meq/L Blood urea nitrogen (BUN) 20 mg/dL Creatinine 1.3 mg/dL Glucose 450 mg/dL Pneumonic infiltrate, right lower lobe The diagnosis of the acid-base disorder should proceed in a stepwise fashion: 1. The normal anion gap (AG) is 8\u201310 meq/L, but in this case, the AG is elevated (20 meq/L). Therefore, the change in AG (\u0394AG) = ~10 meq/L. 2."
        },
        {
            "id": "InternalMed_Harrison_3650",
            "title": "InternalMed_Harrison",
            "content": "A 44-year-old woman was referred from a local hospital after presenting with flaccid paralysis. Severe hypokalemia was documented (2.0 meq/L), and an infusion containing KCl was initiated. PART 2 Cardinal Manifestations and Presentation of Diseases Sodium 140 meq/L Potassium 2.6 meq/L Chloride 115 meq/L Bicarbonate 15 meq/L Anion gap 10 meq/L BUN 22 mg/dL Creatinine 1.4 mg/dL pH 7.32 U PaCO2 30 mmHg HCO3\u2212 15 meq/L Rheumatoid factor positive, anti-Ro/SS-A positive, and anti-La/SS-B positive pH = 6.0, normal sediment without white or red blood cell casts and no bacteria. The urine protein-to-creatinine ratio was 0.150 g/g. Urinary electrolyte values were: Na+ 35, K+ 40, Cl\u2212 18 meq/L. Therefore, the urine anion gap was positive, indicating low urine NH4+ excretion."
        },
        {
            "id": "InternalMed_Harrison_3641",
            "title": "InternalMed_Harrison",
            "content": "A 76-year-old woman presented with a several-month history of diarrhea, with marked worsening over the 2\u20133 weeks before admission (up to 12 stools a day). Review of systems was negative for fever, orthostatic dizziness, nausea and vomiting, or headache. Past medical history included hypertension, kidney stones, and hypercholesterolemia; medications included atenolol, spironolactone, and lovastatin. She also reliably consumed >2 L of liquid per day in management of the nephrolithiasis. The patient received 1 L of saline over the first 5 h of her hospital admission. On examination at hour 6, the heart rate was 72 sitting and 90 standing, and blood pressure was 105/50 mmHg lying and standing. Her jugular venous pressure (JVP) was indistinct with no peripheral edema. On abdominal examination, the patient had a slight increase in bowel sounds but a nontender abdomen and no organomegaly."
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "InternalMed_Harrison_30887",
            "title": "InternalMed_Harrison",
            "content": "Acute Subdural Hematoma (Fig. 457e-3) Direct cranial trauma may be minor and is not required for acute subdural hemorrhage to occur, especially in the elderly and those taking anticoagulant medications. Acceleration forces alone, as from whiplash, are sometimes sufficient to produce subdural hematoma. Up to one-third of patients have a lucid interval lasting minutes to hours before coma supervenes, but most are drowsy or comatose from the moment of injury. A unilateral headache and slightly enlarged pupil on the side of the hematoma are frequently, but not invariably, present. Stupor or coma, hemiparesis, and unilateral pupillary enlargement are signs of larger hematomas. In an acutely deteriorating patient, burr (drainage) holes or an emergency craniotomy are required. Small subdural hematomas may be asymptomatic and usually do not require evacuation if they do not enlarge."
        },
        {
            "id": "Neurology_Adams_7162",
            "title": "Neurology_Adams",
            "content": "The need for surgical intervention during the acute posttraumatic period is decided by two factors: the clinical status of the patient and the findings on imaging. The presence of a subdural or epidural clot that is causing a shift of central brain structures calls for evacuation of the collection. The approach to these lesions has been discussed earlier. Should the elevated ICP not respond to this procedure or to the standard osmotic agents and other medical measures outlined earlier, or should the condition of the patient and vital signs then begin to deteriorate (heart rate rising, temperature rising or falling below normal, state of consciousness worsening, hemiplegia, plantar reflexes more clearly extensor), a renewed search must be undertaken for a late-occurring cerebral hemorrhage. Usually in these clinical circumstances, CT scanning will disclose a new or enlarged epidural, subdural, or intracerebral hematoma, or worsened cerebral edema. If death or severe disability is to be"
        },
        {
            "id": "Physiology_Levy_321",
            "title": "Physiology_Levy",
            "content": "Because the extracellular fluid within the CNS communicates with the CSF, the composition of the CSF is a useful indicator of the composition of the extracellular environment of neurons in the brain and spinal cord. The main constituents of CSF in the lumbar cistern are listed in Table 4.2. For comparison the concentrations of the same constituents in blood are also given. CSF has a lower concentration of K+ , glucose, and protein but a greater concentration of Na+ and Cl\u2212 than blood does. Furthermore, CSF contains practically no blood cells. The increased concentration of Na+ and Cl\u2212 enables CSF to be isotonic to blood. The pressure in the CSF column is about 120 to 180 mm H2O when a person is recumbent. The rate at which CSF is formed is relatively independent of the pressure in the Na+ (mEq/L)148136\u2013145K+ (mEq/L)2.93.5\u20135Cl\u2212 (mEq/L)120\u2013130100\u2013106Glucose(mg/dL)50\u20137570\u2013100Protein(mg/dL)15\u2013456.8\u00d7 103pH7.3 FromWillisWD,GrossmanRG.Medical Neurobiology. 3rded.StLouis:Mosby;1981."
        },
        {
            "id": "Pharmacology_Katzung_1490",
            "title": "Pharmacology_Katzung",
            "content": "Ramin Sam, MD, Harlan E. Ives, MD, PhD, & David Pearce, MD A 65-year-old man has a history of diabetes and chronic kidney disease with baseline creatinine of 2.2 mg/dL. Despite five different antihypertensive drugs, his clinic blood pres-sure is 176/92 mm Hg; he has mild dyspnea on exertion and 2\u20133+ edema on exam. He has been taking furosemide 80 mg twice a day for 1 year now. At the clinic visit, hydrochlorothi-azide 25 mg daily is added for better blood pressure control and also to treat symptoms and signs of fluid overload. Two weeks later, the patient presents to the emergency depart-ment with symptoms of weakness, anorexia, and generalized malaise. His blood pressure is now 91/58 mm Hg, and he has lost 15 kg in 2 weeks. His laboratory tests are signifi-cant for a serum creatinine of 10.8 mg/dL. What has led to the acute kidney injury? What is the reason for the weight loss? What precautions could have been taken to avoid this hospitalization?"
        },
        {
            "id": "Neurology_Adams_4477",
            "title": "Neurology_Adams",
            "content": "3 to 4 h and furosemide 20 to 40 mg administered to prevent fluid overload. In order to avoid osmotic demyelination, a safe clinical rule is to raise the serum sodium by no more than 12 mEq/L in the first 24 h and by no more than 20 mEq/L in 48 h."
        },
        {
            "id": "InternalMed_Harrison_3665",
            "title": "InternalMed_Harrison",
            "content": "Potassium 3.7 1.7 3.5 meq/L 7.47 Creatinine 2.8 2.9 2.3 mg/dL Magnesium 1.3 1.6 2.4 mg/dL Albumin 3.4 2.8 2.3 Total bilirubin 0.65 5.19 5.5 Abbreviations: ACTH, adrenocorticotropic hormone; HD2, hospital day 2; PTA, prior to admission. The patient\u2019s hospital course was complicated by acute respiratory failure attributed to pulmonary embolism; he died 2 weeks after admission. Why was this patient hypokalemic? Why was he weak? Why did he have an alkalosis? This patient suffered from metastatic small-cell lung cancer, which was persistent despite several rounds of chemotherapy and radiotherapy. He presented with profound hypokalemia, alkalosis, hypertension, severe weakness, jaundice, and worsening liver function tests."
        },
        {
            "id": "Pediatrics_Nelson_3459",
            "title": "Pediatrics_Nelson",
            "content": "Fluid therapy depends on the volume status and urine output. If hypovolemia is present, intravascular volume should be expanded by intravenous administration of saline. If hypervolemia is present, 1 to 2 mg/kg of furosemide and fluid restriction may be attempted. If the patient is relatively euvolemic, then the total fluid input should be adjusted to meet the total Urine output Low Low, normal, or high Low or normal Urinalysis Normal RBCs, WBCs, protein, casts Variable Urine Na+ (mEq/L) <15 <20\u201330 >40 >50 Variable, may be >40 FENa* (%) <1 <2.5 >2 >2.5 Variable, may be >2 Urine osmolality >500 >350 \u223c300 \u223c300 Variable, may be (mOsm/L) Renal ultrasound Normal Increased echogenicity, decreased Hydronephrosis corticomedullary differentiation FENa, Fractional excretion of sodium; RBCs, red blood cells; WBCs, white blood cells. *FENa (%) = [(urine sodium/plasma sodium) \u00f7 (urine creatinine/plasma creatinine)] \u00d7 100."
        },
        {
            "id": "InternalMed_Harrison_3365",
            "title": "InternalMed_Harrison",
            "content": "Urinary tract obstruction accounts for <5% of cases of acute renal failure but is usually reversible and must be ruled out early in the evaluation (Fig. 61-1). Since a single kidney is capable of adequate BUN/PCr ratio Urine sodium UNa, meq/L Urine osmolality, mosmol/L H2O Fractional excretion of sodiuma Urine/plasma creatinine UCr/PCr Urinalysis (casts) FENa = . PNa \u00d7 >20:1 granular 10\u201315:1 >40 <350 >2% <20 Muddy brown Abbreviations: BUN, blood urea nitrogen; PCr, plasma creatinine concentration; PNa, plasma sodium concentration; UCr, urine creatinine concentration; UNa, urine sodium concentration."
        },
        {
            "id": "Surgery_Schwartz_656",
            "title": "Surgery_Schwartz",
            "content": "water restriction and, if severe, the administration of sodium. In patients with normal renal function, symptomatic hyponatremia usually does not occur until the serum sodium level is \u2264120 mEq/L. If neurologic symptoms are present, 3% normal saline should be used to increase the sodium by no more than 1 mEq/L per hour until the serum sodium level reaches 130 mEq/L or neurologic symptoms are improved. Correction of asymptomatic hyponatremia should increase the sodium level by no more than 0.5 mEq/L per hour to a maxi-mum increase of 12 mEq/L per day, and even more slowly in chronic hyponatremia. The rapid correction of hyponatremia can lead to pontine myelinolysis,30 with seizures, weakness, paresis, akinetic movements, and unresponsiveness, and may result in permanent brain damage and death. Serial magnetic resonance imaging may be necessary to confirm the diagnosis.31Potassium Hyperkalemia Treatment options for symptomatic hyperka-lemia are listed in Table 3-14. The goals of therapy"
        },
        {
            "id": "InternalMed_Harrison_32553",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: P, plasma; RC, red cells; S, serum; WB, whole blood. Electrolytes Sodium 137\u2013145 mmol/L 137\u2013145 meq/L Potassium 2.7\u20133.9 mmol/L 2.7\u20133.9 meq/L Calcium 1.0\u20131.5 mmol/L 2.1\u20133.0 meq/L Magnesium 1.0\u20131.2 mmol/L 2.0\u20132.5 meq/L Chloride 116\u2013122 mmol/L 116\u2013122 meq/L CO2 content 20\u201324 mmol/L 20\u201324 meq/L PCO2 6\u20137 kPa 45\u201349 mmHg pH 7.31\u20137.34 Glucose 2.22\u20133.89 mmol/L 40\u201370 mg/dL Lactate 1\u20132 mmol/L 10\u201320 mg/dL Total protein: Lumbar 0.15\u20130.5 g/L 15\u201350 mg/dL Cisternal 0.15\u20130.25 g/L 15\u201325 mg/dL Ventricular 0.06\u20130.15 g/L 6\u201315 mg/dL Albumin 0.066\u20130.442 g/L 6.6\u201344.2 mg/dL IgG 0.009\u20130.057 g/L 0.9\u20135.7 mg/dL IgG indexb 0.29\u20130.59 Oligoclonal bands (OGB) <2 bands not present in matched serum sample"
        },
        {
            "id": "Pharmacology_Katzung_368",
            "title": "Pharmacology_Katzung",
            "content": "A 40-year-old woman presents to the emergency department of her local hospital somewhat disoriented, complaining of midsternal chest pain, abdominal pain, shaking, and vomiting for 2 days. She admits to having taken a \u201chandful\u201d of Lorcet (hydrocodone/acetaminophen, an opioid/nonopioid analgesic combination), Soma (carisoprodol, a centrally acting muscle relaxant), and Cymbalta (duloxetine HCl, an antidepressant/ antifibromyalgia agent) 2 days earlier. On physical examina-tion, the sclera of her eyes shows yellow discoloration. Labora-tory analyses of blood drawn within an hour of her admission reveal abnormal liver function as indicated by the increased indices: alkaline phosphatase 302 (41\u2013133),* alanine amino-transferase (ALT) 351 (7\u201356),* aspartate aminotransferase (AST) 1045 (0\u201335),* bilirubin 3.33 mg/dL (0.1\u20131.2),* and pro-thrombin time of 19.8 seconds (11\u201315).* In addition, plasma bicarbonate is reduced, and she has ~45% reduced glomerular filtration rate from the normal value"
        }
    ],
    "scores": [
        0.029258921112745716,
        0.029032860343539954,
        0.028671846096929333,
        0.02812886317559215,
        0.027623727623727626,
        0.02715492137449039,
        0.02555386593018886,
        0.024712052276076014,
        0.02469974922275755,
        0.024169512341241314,
        0.0236691732801056,
        0.02215647600262985,
        0.021613023952095807,
        0.020864661654135336,
        0.020837130705551758,
        0.01991659581541461,
        0.01941643046807295,
        0.019237883832778392,
        0.01913919413919414,
        0.018672919923571306,
        0.017879948914431672,
        0.017494270435446907,
        0.016811471356925903,
        0.01664259679526855,
        0.016609706083390293,
        0.016510727722381543,
        0.015873015873015872,
        0.01568627450980392,
        0.01562592482983131,
        0.015518796992481203,
        0.014910163582729955,
        0.014732475268588448
    ]
}